Elena Gabriela Chiorean, MD, discusses the role of genetic testing in pancreatic cancer.
Gabriela Chiorean, MD
Advertisement
Articles by Gabriela Chiorean, MD
Gabriela Chiorean, MD, associate professor of Medicine at the University of Washington, discusses adverse events of the phase I study of combination therapies for patients with pancreatic cancer.
Advertisement
Latest Updated Articles
Dr. Chiorean on the Role of Genetic Testing in Pancreatic CancerPublished: January 7th 2021 | Updated:
Dr. Chiorean on Combination Therapies for Pancreatic CancerPublished: January 26th 2017 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
5